USPTO Examiner SINGH SATYENDRA K - Art Unit 1657

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18630584METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPYApril 2024August 2024Allow510YesNo
18595392LARGE-SCALE PRODUCTION OF MYCELIUM-BASED TEXTILES AT MUSHROOM FARM FACILITIESMarch 2024May 2025Allow1410YesNo
18419836ENZYME-ASSISTED ATRP PROCEDURESJanuary 2024April 2025Abandon1410NoNo
18524494BACTERIAL CULTURES AND METHODS FOR PRODUCTION OF ALGINATENovember 2023March 2025Allow1511YesNo
18523358METHODS OF PROCESSING LIGNOCELLULOSIC BIOMASS USING SINGLE-STAGE AUTOHYDROLYSIS AND ENZYMATIC HYDROLYSIS WITH C5 BYPASS AND POST-HYDROLYSISNovember 2023May 2025Allow1810NoNo
18520265TISSUE PRESERVATION SYSTEMNovember 2023December 2024Abandon1310NoNo
18558863A Bioreactor and Process for Forming Polyhydroxybutyrate Directly from Depolymerized PolyhydroxybutyrateNovember 2023June 2025Allow1911YesNo
18382410SYSTEM FOR GROWING FUNGAL MATERIALSOctober 2023April 2025Abandon1811NoNo
18371651COMPOSITIONS AND METHOD OF USE FOR H5 COMPETENT BIFIDOBACTERIUM LONGUM SUBSP. INFANTISSeptember 2023June 2025Allow2111YesNo
18455533CELLULOSE NANOFIBRILLAR BIOINK FOR 3D BIOPRINTING FOR CELL CULTURING, TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONSAugust 2023February 2025Abandon1801NoNo
18220535METHODS TO GENERATE POLYMER SCAFFOLDS HAVING A GRADIENT OF CROSSLINKING DENSITYJuly 2023May 2025Abandon2221NoNo
18341692METHODS OF PREPARING T CELLS FOR T CELL THERAPYJune 2023February 2025Abandon2020YesNo
18319085METHOD OF PRODUCING THIN ENZYME-BASED SENSING LAYERS ON PLANAR SENSORSMay 2023December 2023Allow700YesNo
18177070SIALYLTRANSFERASES FOR IN VIVO SYNTHESIS OF 3'SLMarch 2023August 2024Allow1811NoNo
18166412METHOD FOR STABILIZATION AND DELIVERY OF THERAPEUTIC MOLECULESFebruary 2023September 2024Allow1930YesNo
18162957CONTROLLED OUTGASSING OF HYPERBARICALLY LOADED MATERIALS FOR THE DELIVERY OF OXYGEN AND OTHER THERAPEUTIC GASES IN BIOMEDICAL APPLICATIONSFebruary 2023September 2024Allow1910YesNo
18104578METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPYFebruary 2023January 2024Allow1100YesNo
18097755OPEN-TOP MICROFLUIDIC DEVICE WITH STRUCTURAL ANCHORSJanuary 2023July 2023Allow601YesNo
17993690SATELLITE CELLS AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAMENovember 2022February 2023Allow300YesNo
18058042MECHANISM BASED QUALITY CONTROL FOR BOTANICAL MEDICINENovember 2022October 2023Allow1000YesNo
17967598TISSUE PRESERVATION SYSTEMOctober 2022August 2023Allow1010YesNo
17995367METHOD FOR PRODUCING SULFATED POLYSACCHARIDE AND METHOD FOR PRODUCING PAPSOctober 2022November 2024Allow2630YesNo
17937553USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTHOctober 2022January 2023Allow300YesNo
17937554USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTHOctober 2022January 2023Allow300YesNo
17934119METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPYSeptember 2022January 2023Allow300YesNo
17942952ENZYME-ASSISTED ATRP PROCEDURESSeptember 2022October 2023Allow1310YesNo
17864154PROCESS FOR TREATING WATERS, SOILS, SEDIMENTS AND/OR SLUDGESJuly 2022March 2025Allow3231YesNo
17778201METHOD FOR PRODUCING 3,5-DIHYDROXY-4-METHOXYBENZYL ALCOHOL FROM PLANKTONMay 2022February 2025Allow3310NoNo
17737424METHOD FOR STABILIZATION AND DELIVERY OF THERAPEUTIC MOLECULESMay 2022November 2022Allow600YesNo
17733531METHODS FOR DETECTION, DETERMINATION, AND ACTIVITY MEASUREMENT OF PEROXIDASE BASED ON CHEMILUMINESCENCEApril 2022September 2023Allow1610NoNo
17728480SYSTEM FOR GROWING FUNGAL MATERIALSApril 2022September 2023Allow1710YesNo
17765548Methods for Isolating Single-Molecule ProductsMarch 2022July 2024Abandon2711NoNo
17763761PROCESSES AND SYSTEMS FOR BIOLOGICAL HYDROGEN PRODUCTION FROM ORGANIC WASTE USING YEASTMarch 2022September 2024Allow3010YesNo
17753324ACTIVITY BASED PROBESFebruary 2022March 2025Allow3611YesNo
17674913Oleaginous Yeast and its applicationFebruary 2022September 2024Allow3110NoNo
17671262MICROBIAL COMPOSITIONS AND METHODSFebruary 2022January 2024Allow2300YesNo
17671479ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS FOR USE IN TREATING REFRACTORY COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASEFebruary 2022September 2024Allow3130YesNo
17634162Production of Fatty Acid Esters Using a Yeast CultureFebruary 2022October 2024Abandon3201NoNo
17583067PapQuin-50 a Quinoa grain-based bacterial growth medium nitrogen sourceJanuary 2022November 2023Allow2101YesNo
17571555HEALTH FOOD FOR PROMOTION OF QUALITY OF SLEEPY AND METABOLISMJanuary 2022March 2024Abandon2610NoNo
17621121OPTIMIZED BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF LEUCINE, ISOLEUCINE, AND/OR VALINEDecember 2021June 2025Abandon4201NoNo
17556966COMPOSITIONS AND METHODS FOR PRODUCING 1,8-DIHYDROXYNAPHTHALENE AND CYCLIC HYDROCARBONS FROM 1,8-DIHYDROXYNAPHTHALENEDecember 2021April 2025Abandon3901NoNo
17551221METHOD FOR EXTRACTING FUNCTIONAL INGREDIENTS OF MULBERRY LEAVES USING ENZYMESDecember 2021February 2025Abandon3801NoNo
17618668METHOD FOR THE PRODUCTION OF IODINATED PROTEINS WITH A DETERMINATED IODINE CONTENTDecember 2021September 2024Allow3301YesNo
17617527ENGINEERED ACETATE KINASE VARIANT ENZYMESDecember 2021December 2024Allow3611NoNo
17615342THERMOSTABLE GLUCOSE OXIDASENovember 2021September 2024Allow3411NoNo
17615160Method of Recovering a Protein from Fermentation Broth Using a Divalent CationNovember 2021August 2024Allow3310YesNo
17614106METHOD FOR THE PRODUCTION OF BIOGASNovember 2021March 2024Allow2710YesNo
17611109NANORG MICROBIAL FACTORIES: LIGHT-DRIVEN RENEWABLE BIOCHEMICAL SYNTHESIS USING QUANTUM DOT-BACTERIA NANO-BIOHYBRIDSNovember 2021April 2025Abandon4101NoNo
17525715Biological and Chemical Process Utilizing Chemoautotrophic Microorganisms for the Chemosynthetic Fixation of Carbon Dioxide and/or Other Inorganic Carbon Sources into Organic Compounds and the Generation of Additional Useful ProductsNovember 2021March 2025Abandon4030NoNo
17595093PURIFIED FISH PROTEASES WITH HIGH SPECIFIC ACTIVITIES AND ITS PROCESS OF PRODUCTIONNovember 2021February 2025Allow3911YesNo
17508361ORAL REHYDRATION COMPOSITION WITH OLIGOSACCHARIDESOctober 2021February 2024Abandon2820NoNo
17605993IN VIVO IMMOBILIZATION OF PROTEINSOctober 2021April 2025Allow4221YesNo
17504858CONTINUOUS FLOW METHOD FOR PREPARING (R)-3-HYDROXY-5-HEXENOATEOctober 2021September 2023Allow2301YesNo
17502445USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTHOctober 2021September 2022Allow1120YesNo
17600767Process For Producing A Fermentation ProductOctober 2021October 2024Abandon3710NoNo
17601045MUT- METHYLOTROPHIC YEASTOctober 2021December 2024Allow3910NoNo
17436512LANTIBIOTICS AND LANTIBIOTIC-PRODUCING BACTERIASeptember 2021January 2025Abandon4101NoNo
17435530LIPID BIOSYNTHESIS AND ABIOTIC STRESS RESILIENCE IN PHOTOSYNTHETIC ORGANISMSSeptember 2021March 2025Abandon4221NoNo
17458929ASPARAGINE FEED STRATEGIES TO IMPROVE CELL CULTURE PERFORMANCE AND MITIGATE ASPARAGINE SEQUENCE VARIANTSAugust 2021August 2024Allow3521YesNo
17432500MODIFIED MICROORGANISMS EXPRESSING SAGA AND RELATED COMPOSITIONS FOR IMMUNOMODULATION AGAINST INFECTION AND CANCER IMMUNOTHERAPYAugust 2021December 2024Allow4011YesNo
17430328GENE FOR TRYPSIN-LIKE SERINE PROTEASE, A PROTEIN ENCODED THEREBY AND USE THEREOFAugust 2021May 2024Allow3310NoNo
17429773Novel Methods for Production of Mannosylerythritol LipidsAugust 2021May 2023Allow2200YesNo
17425261SUPERNEGATIVELY CHARGED PROTEINS AND USES THEREOFJuly 2021February 2025Allow4321YesNo
17380226NANOREACTOR USING POLYION COMPLEX POLYMERSOMES, AND METHOD FOR PRODUCING SAMEJuly 2021December 2024Abandon4101NoNo
17375551SCHIZOCHYTRIUM STRAIN AND USE THEREOF, MICROBIAL OIL CONTAINING DHA AT SN-2 POSITION AND PREPARATION AND USE THEREOFJuly 2021January 2025Allow4221YesNo
17374966SUPERFLUIDS DISRUPTION OF SACCHAROMYCES CEREVISIAE (YEAST), CELL WALL DISINTEGRATION INTO NANOPARTICLES AND FRACTIONATION INTO BETA-GLUCANS, CHITIN AND MANNANS (MANNOPROTEINS)July 2021April 2025Abandon4621NoNo
17372372PROCESS FOR REDUCING THE ACTIVITY OF MICROBIAL CONTAMINATION IN A YEAST MEDIUMJuly 2021July 2025Allow4831YesNo
17419122PICHIA PASTORIS MUTANT STRAIN FOR EXPRESSING EXOGENOUS GENEJune 2021December 2024Allow4211NoNo
17350366METHOD OF SCREENING ATP11C OR CDC50A INHIBITORJune 2021April 2023Allow2210YesNo
17347793Do-it-Yourself Kit for the detection of E. coli and total coliform in waterJune 2021May 2024Abandon3611NoNo
17345660DEPHOSPHORYLATED LYSOSOMAL STORAGE DISEASE PROTEINS AND METHODS OF USE THEREOFJune 2021September 2024Abandon3901NoNo
17343501Processes, methods and rationale for manufacturing pre- probiotic dietary supplements aimed at protecting the human body from the harmful effects of electromagnetic radiations through quantum entanglement of DNA repair genes elicited by natural superluminal particles inducing photosynthesis via Cherenkov effectJune 2021February 2024Allow3211YesNo
17299809METHOD OF PRODUCING FUNGAL MATS AND MATERIALS MADE THEREFROMJune 2021December 2024Allow4321YesNo
17309448METHOD FOR PRODUCING YEAST CONTAINING RICH-TASTE-IMPARTING SUBSTANCE AND METHOD FOR PRODUCING YEAST EXTRACT CONTAINING RICH-TASTE-IMPARTING SUBSTANCEMay 2021June 2024Allow3710YesNo
17329960METHODS OF PROCESSING LIGNOCELLULOSIC BIOMASS USING SINGLE-STAGE AUTOHYDROLYSIS AND ENZYMATIC HYDROLYSIS WITH C5 BYPASS AND POST-HYDROLYSISMay 2021August 2023Allow2720YesNo
17326742SYSTEM FOR GROWING FUNGAL MATERIALSMay 2021March 2022Allow1010YesNo
17293832GLYCOGEN-NULL METHANOTROPHS AND USES THEREOFMay 2021October 2024Allow4111YesNo
17314930METHOD OF PRODUCING THIN ENZYME-BASED SENSING LAYERS ON PLANAR SENSORSMay 2021March 2023Allow2200YesNo
17306189CO2 SEQUESTRATION AND CREATION OF CALCIUM CARBONATES THROUGH MICROBIAL INDUCED CARBONATE PRECIPITATIONMay 2021March 2024Allow3521YesNo
17286669METHOD FOR PREPARING ORGANIC MOLECULES BY ANAEROBIC FERMENTATIONApril 2021June 2023Allow2610YesNo
17230155METHOD FOR PRODUCING CIS-UNSATURATED FATTY ACID BY RECOMBINANT CANDIDA RUGOSA LIPASE 1 (rCRL1)April 2021April 2023Allow2410YesNo
17226333MITOCHONDRIA ISOLATIONApril 2021September 2023Allow2911YesNo
17282857LACTOCOCCUS LACTIS EXPRESSION SYSTEM FOR DELIVERING PROTEINS EFFICACIOUS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERSApril 2021January 2025Abandon4611NoNo
16627710DIRECT DETECTION OF THE ACTIVE FORM OF BETA-LACTAM-HYDROLYSING ENZYMES BY USING MASS SPECTROPHOTOMETRYMarch 2021December 2021Allow2400YesNo
17204432METHODS AND COMPOSITION FOR CONTROLLING MAP INFECTION AND CONTAMINATIONMarch 2021November 2024Abandon4411NoNo
17203491MICROBIAL SOIL ENHANCEMENTMarch 2021July 2023Abandon2821NoNo
17267028COMPOSITION FOR INHIBITING FCERI EXPRESSION AND METHOD FOR INHIBITING FCERI EXPRESSIONFebruary 2021March 2025Abandon4921NoNo
17160617OPEN-TOP MICROFLUIDIC DEVICE WITH STRUCTURAL ANCHORSJanuary 2021September 2021Allow801YesNo
17139245IMMOBILIZED ENZYME FOR DIRECTIONALLY CATALYZING ESTERIFICATION REACTION AND PREPARATION METHOD AND USE THEREOFDecember 2020August 2022Abandon2001NoNo
17125322Methods of Making Spheroids Including Biologically-Relevant MaterialsDecember 2020October 2023Allow3320YesNo
17253266LIPOLYTIC ENZYME VARIANTSDecember 2020August 2024Allow4411YesNo
17252676METHYL SULFONYL METHANE-CONTAINING COMPOSITION FOR PREVENTING OR ALLEVIATING OBESITY, FATTY LIVER, AND DIABETESDecember 2020April 2024Abandon4010NoNo
17059928COMPOSTIONS AND METHOD OF USE FOR H5 COMPETENT BIFIDOBACTERIUM LONGUM SUBSP. INFANTISNovember 2020November 2023Abandon3611NoNo
16950719BIOLOGICAL INDICATOR FOR RAPID VERIFICATION OF DISINFECTION OR STERILIZATIONNovember 2020June 2023Abandon3101NoNo
17081745SYSTEM FOR GROWING FUNGAL MATERIALSOctober 2020April 2021Allow600YesNo
17077581DETECTION OF BETA-HEMOLYTIC PATHOGENSOctober 2020January 2023Allow2700YesNo
17036110METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPYSeptember 2020September 2022Allow2400YesNo
16980198BACTERIAL CULTURES AND METHODS FOR PRODUCTION OF ALGINATESeptember 2020August 2023Allow3621YesNo
16772578CELL PROLIFERATION INHIBITOR AND CANCER TREATMENT OR PREVENTION PHARMACEUTICAL COMPOSITION INCLUDING CELL PROLIFERATION INHIBITORAugust 2020March 2024Abandon4510NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SINGH, SATYENDRA K.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
14
Examiner Affirmed
9
(64.3%)
Examiner Reversed
5
(35.7%)
Reversal Percentile
56.0%
Higher than average

What This Means

With a 35.7% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
48
Allowed After Appeal Filing
15
(31.2%)
Not Allowed After Appeal Filing
33
(68.8%)
Filing Benefit Percentile
45.2%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 31.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner SINGH, SATYENDRA K - Prosecution Strategy Guide

Executive Summary

Examiner SINGH, SATYENDRA K works in Art Unit 1657 and has examined 701 patent applications in our dataset. With an allowance rate of 61.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.

Allowance Patterns

Examiner SINGH, SATYENDRA K's allowance rate of 61.8% places them in the 15% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by SINGH, SATYENDRA K receive 1.97 office actions before reaching final disposition. This places the examiner in the 64% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SINGH, SATYENDRA K is 36 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +73.7% benefit to allowance rate for applications examined by SINGH, SATYENDRA K. This interview benefit is in the 99% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 24.3% of applications are subsequently allowed. This success rate is in the 26% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 22.6% of cases where such amendments are filed. This entry rate is in the 21% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 54.5% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 45% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 64.1% of appeals filed. This is in the 38% percentile among all examiners. Of these withdrawals, 64.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 48.1% are granted (fully or in part). This grant rate is in the 56% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 7.0% of allowed cases (in the 93% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.